Biotech Companies Will Not Merge: A Proposed Merger Between Two Dunedin Biotechnology Companies, Botry Zen And Pharma Zen, Is Off

"The directors of both companies have agreed that the maximisation of corporate value in each case will be best achieved by maintaining the existing separate entity status," Pharma Zen chairman Max Shepherd said in a statement.